Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2024 / Honorees / Douglas J Rhee

Douglas J. Rhee

  • Profile

About Douglas J. Rhee

Professor and Chair, Department of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

What major industry trends are catching your attention right now?

The treatment of glaucoma, based on the evidence, is evolving towards procedural intervention as first-line therapy.

What is a little-known fact about you?

Some people have asked me if I had ever tried to do standup comedy before. I did try in college once, and I was a failure; no one laughed. Although, that might not be little known about me.

Make a bold prediction for the future of ophthalmology?

I am so excited by the advancements in foundational knowledge, diagnostic, therapeutic, and decision support technologies. I predict that these will enable us to continue ophthalmology’s leadership in the future of medical care delivery. As we know, a few decades ago, the vast majority of ophthalmic surgeries involved an in-patient hospital stay. Technology advancements, combined with brave and pioneering clinicians, moved nearly all of our procedures into the outpatient setting. I believe that the evolutionary and revolutionary advancements made in all four of the aforementioned domains will allow us to develop disease modifying treatments, cures at the genetic level, and shift even more care into physician offices and patients’ homes, providing better outcomes and greater convenience for our patients.

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: